Literature DB >> 9928283

High affinity of SDZ HTF-919 related molecules for calf and human caudate 5-HT4 receptors.

D Hoyer1, D Fehlmann, D Langenegger, J Kummer, R Giger, H Mattes, A Probst, H J Pfannkuche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9928283     DOI： 10.1111/j.1749-6632.1998.tb10217.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

Review 1.  New therapies for functional bowel diseases.

Authors:  B Coulie; M Camilleri
Journal:  Curr Gastroenterol Rep       Date:  2000-10

Review 2.  Clinical pharmacokinetics of tegaserod, a serotonin 5-HT(4) receptor partial agonist with promotile activity.

Authors:  Silke Appel-Dingemanse
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Tegaserod.

Authors:  L J Scott; C M Perry
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 4.  Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women.

Authors:  Antona J Wagstaff; James E Frampton; Katherine F Croom
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.

Authors:  D T Beattie; J A M Smith; D Marquess; R G Vickery; S R Armstrong; T Pulido-Rios; J L McCullough; C Sandlund; C Richardson; N Mai; P P A Humphrey
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

Review 6.  Tegaserod for the Treatment of Irritable Bowel Syndrome.

Authors:  Valentina Noemi Madia; Antonella Messore; Francesco Saccoliti; Valeria Tudino; Alessandro De Leo; Daniela De Vita; Martina Bortolami; Luigi Scipione; Ivano Pindinello; Roberta Costi; Roberto Di Santo
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.